Cases & Deals

ToolGen defends revolutionary CRISPR technology patent

Clients ToolGen, Inc.

Jones Day is acting for ToolGen, Inc. in relation to a challenge to its patent rights concerning CRISPR, a technology that has revolutionized the field of molecular biology including gene editing in the medical, biotechnology, and agricultural and farming industries.

Grant Fisher v. ToolGen Incorporated [2018] APO 65

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.